Sucrose fatty acid sulphate esters as novel vaccine adjuvants: effect of the chemical composition
- 1 December 2004
- Vol. 23 (6) , 743-754
- https://doi.org/10.1016/j.vaccine.2004.07.021
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Results of clinical trials with an allogeneic melanoma tumor cell lysate vaccine: Melacine®Seminars in Cancer Biology, 2003
- Monophosphoryl Lipid A (MPL) Formulations for the Next Generation of VaccinesMethods, 1999
- Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59Vaccine, 1995
- A novel non-mineral oil-based adjuvant. I. Efficacy of a synthetic sulfolipopolysaccharide in a squalane-in-water emulsion in laboratory animalsVaccine, 1994
- Liposomes as antigen carriers and adjuvants in vivoResearch in Immunology, 1992
- The iscom structure as an immune-enhancing moiety: experience with viral systemsResearch in Immunology, 1992
- Syntex adjuvant formulationResearch in Immunology, 1992
- DDA as an immunological adjuvantResearch in Immunology, 1992
- Bacterial cell wall products as adjuvants: early interferon gamma as a marker for adjuvants that enhance protective immunityResearch in Immunology, 1992
- Freund's complete adjuvant: an effective but disagreeable formulaResearch in Immunology, 1992